Related Experiment Video
Updated: Nov 8, 2025

Isolation and Excision of Murine Aorta; A Versatile Technique in the Study of Cardiovascular Disease
Published on: November 24, 2014
Progress in aorta and peripheral cardiovascular disease research
Lucia Mazzolai1, Adriano Alatri1, Alessandra Bura Rivière2
1Division of Angiology, Heart and Vessel Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Insights
Key 2020 research in vascular diseases includes new insights into aortic aneurysm, fibromuscular dysplasia genetics, and NADPH oxidases. Advances in vulnerable plaque imaging and dual antithrombotic therapy for peripheral artery disease are also highlighted.
Area of Science:
- Vascular Biology and Medicine
- Cardiovascular Research
Background:
- Despite focus on COVID-19, significant research advanced understanding of aorta and peripheral vascular diseases in 2020.
- These advancements are poised to impact clinical practice in vascular medicine.
Purpose of the Study:
- To review key research published in 2020 concerning aorta and peripheral vascular diseases.
- To highlight novel findings in pathophysiology, diagnostics, and therapeutics for vascular conditions.
Main Methods:
- Review of significant studies published in 2020 on aortic and peripheral vascular diseases.
- Synthesis of findings related to pathophysiology, genetics, imaging, and clinical trials.
Main Results:
- Pathophysiology of aortic aneurysm and dissection suggests kinase inhibitors as potential therapies.
- Proteogenomic study identified a novel gene for fibromuscular dysplasia (FMD) and a potential blood test.
- NADPH oxidases' role in endothelial cell differentiation noted, with implications for cell therapy.
- Magnetic resonance imaging features of vulnerable plaque identified as a stroke risk factor.
- Clinical trials demonstrated benefits of dual antithrombotic therapy (aspirin plus rivaroxaban) for lower extremity peripheral artery disease.
Conclusions:
- Recent research offers new therapeutic targets (kinase inhibitors) and diagnostic approaches (FMD blood test) for vascular diseases.
- Advances in understanding plaque vulnerability and effective treatments for peripheral artery disease are crucial for clinical practice.
Abstract:
Although coronavirus disease 2019 seems to be the leading topic in research number of outstanding studies have been published in the field of aorta and peripheral vascular diseases likely affecting our clinical practice in the near future. This review article highlights key research on vascular diseases published in 2020. Some studies have shed light in the pathophysiology of aortic aneurysm and dissection suggesting a potential role for kinase inhibitors as new therapeutic options. A first proteogenomic study on fibromuscular dysplasia (FMD) revealed a promising novel disease gene and provided proof-of-concept for a protein/lipid-based FMD blood test. The role of NADPH oxidases in vascular physiology, and particularly endothelial cell differentiation, is highlighted with potential for cell therapy development. Imaging of vulnerable plaque has been an intense field of research. Features of plaque vulnerability on magnetic resonance imaging as an under-recognized cause of stroke are discussed. Major clinical trials on lower extremity peripheral artery disease have shown added benefit of dual antithrombotic (aspirin plus rivaroxaban) treatment.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction

